Your browser doesn't support javascript.
loading
Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
Flores-Climente, Víctor; Rozas-Muñoz, Eduardo; Martínez-Grau, Ainhoa; Aucouturier, Françoise; Luna, Sabina; Baselga, Eulalia.
Afiliação
  • Flores-Climente V; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Rozas-Muñoz E; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Martínez-Grau A; Barraquer Ophthalmology Centre, Barcelona, Spain.
  • Aucouturier F; Department of Immunology, Saint-Louis Hospital, Paris, France.
  • Luna S; Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Baselga E; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Pediatr Dermatol ; 36(6): 984-985, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31448438
ABSTRACT
Ocular mucous membrane pemphigoid (MMP) is a chronic autoimmune blistering disease that usually affects elderly patients being extremely rare in pediatric population. Despite aggressive immunosuppressive therapy, ocular MMP may progress causing significant morbidity. Herein, we describe a toddler with ocular MMP successfully treated with rituximab.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Mucomembranoso Benigno / Rituximab / Fatores Imunológicos Limite: Child, preschool / Humans / Male Idioma: En Revista: Pediatr Dermatol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Mucomembranoso Benigno / Rituximab / Fatores Imunológicos Limite: Child, preschool / Humans / Male Idioma: En Revista: Pediatr Dermatol Ano de publicação: 2019 Tipo de documento: Article